Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2025 Filed Oct 6, 2025 18:57 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 11,684 | $152.23 | $1,778,675.18 |
DisclosureSEC source: 0000080424-25-000208 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,932.232 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 18:58 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 4,252 | $152.23 | $647,289.19 |
DisclosureSEC source: 0000080424-25-000209 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,992.0273 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:51 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,670 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000189 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,670 Underlying: Common Stock · 42,670 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:52 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,065 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000190 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,065 Underlying: Common Stock · 49,065 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:53 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 14,163 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000191 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 14,163 Underlying: Common Stock · 14,163 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:53 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 62,338 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000191 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,338 Underlying: Common Stock · 62,338 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:54 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 105,581 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000192 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,581 Underlying: Common Stock · 105,581 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:54 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantCommon Stock | 22,849 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000192 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,885.3817 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:55 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,779 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000193 · form4.xml · derivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,779 Underlying: Common Stock · 13,779 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:56 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 68,869 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000194 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,869 Underlying: Common Stock · 68,869 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:57 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantStock Option (Right to Buy) · Derivative | 62,338 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000195 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,338 Underlying: Common Stock · 62,338 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:00 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 46,754 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000196 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,754 Underlying: Common Stock · 46,754 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:00 UTC |
Coombe Gary ACEO - Grooming
|
GrantCommon Stock | 3,373 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000196 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,351.145 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:01 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 169,684 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000197 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,684 Underlying: Common Stock · 169,684 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:01 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 12,241 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000197 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,616.232 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:02 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,738 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000198 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,738 Underlying: Common Stock · 22,738 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:02 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 4,921 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000198 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,762.1704 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:05 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 68,869 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000199 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,869 Underlying: Common Stock · 68,869 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:06 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 77,648 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000200 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,648 Underlying: Common Stock · 77,648 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:06 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 5,602 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000200 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,244.0273 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:09 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 26,531 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000201 · form4.xml · derivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,531 Underlying: Common Stock · 26,531 shares Expires 2035-10-01 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:09 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 5,742 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000201 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,177.8354 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 13:32 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,852 | $0.00 Strike: $156.83 | $0.00 |
DisclosureSEC source: 0000080424-25-000164 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,852 Underlying: Common Stock · 6,852 shares Expires 2035-09-14 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 13:34 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 26,231 | $0.00 Strike: $156.83 | $0.00 |
DisclosureSEC source: 0000080424-25-000165 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,231 Underlying: Common Stock · 26,231 shares Expires 2035-09-14 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 13:35 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 11,420 | $0.00 Strike: $156.83 | $0.00 |
DisclosureSEC source: 0000080424-25-000166 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,420 Underlying: Common Stock · 11,420 shares Expires 2035-09-14 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:02 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000146 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,100.9784 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:06 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 220 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000148 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,397.6912 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:07 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000149 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,946.5131 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:08 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000150 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,843.0241 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:09 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000151 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,419.5944 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:27 UTC |
ARNOLD CRAIGDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000155 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703.4862 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 17:37 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 197 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000160 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,166.4401 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 18:59 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000163 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,517.5268 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| August 29, 2025 Filed Aug 29, 2025 20:34 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 1,000 | $156.84 | $156,835.00 |
DisclosureSEC source: 0000080424-25-000144 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,435.8354 Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 16:48 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 766 | $158.16 | $121,150.02 |
DisclosureSEC source: 0000080424-25-000139 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,895.7069 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 16:48 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 10,697 | $158.16 | $1,691,826.82 |
DisclosureSEC source: 0000080424-25-000139 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,529.5056 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 16:49 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 10,194 | $158.16 | $1,612,272.85 |
DisclosureSEC source: 0000080424-25-000140 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,978.145 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 16:51 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
SaleCommon Stock | 9,554 | $158.16 | $1,511,050.13 |
DisclosureSEC source: 0000080424-25-000141 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,886.4892 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:05 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 9,100 | $157.27 | $1,431,191.58 |
DisclosureSEC source: 0000080424-25-000126 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,295.0856 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:07 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 319 | $157.27 | $50,170.34 |
DisclosureSEC source: 0000080424-25-000127 · form4.xml · nonDerivative · entry 2 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,703.9031 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:08 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 13,039 | $157.27 | $2,050,693.08 |
DisclosureSEC source: 0000080424-25-000128 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,036.3817 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:11 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 40,119 | $157.27 | $6,309,667.58 |
DisclosureSEC source: 0000080424-25-000130 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,375.232 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:16 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 9,849 | $157.27 | $1,548,989.66 |
DisclosureSEC source: 0000080424-25-000131 · form4.xml · nonDerivative · entry 2 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,421.8895 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:18 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 606 | $157.27 | $95,307.92 |
DisclosureSEC source: 0000080424-25-000132 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,106.0044 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:25 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 11,638 | $157.27 | $1,830,352.48 |
DisclosureSEC source: 0000080424-25-000135 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,642.0273 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 23:37 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 6,167 | $157.27 | $969,907.52 |
DisclosureSEC source: 0000080424-25-000136 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,435.8354 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 16:34 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 8,596 | $157.27 | $1,351,925.58 |
DisclosureSEC source: 0000080424-25-000138 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,990.9326 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 19, 2025 Filed Aug 27, 2025 18:07 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 15,314 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000142 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,841.1704 F1 · date: The late filing is due to an inadvertent administrative error and not any error of the reporting person. F2 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 23:03 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantCommon Stock | 21,518 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000125 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,586.9326 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 23:05 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantCommon Stock | 22,649 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000126 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,395.0856 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.